Recognizing the urgent unmet need for treating patients battling advanced melanoma, the Stanford Cancer Institute (SCI) is establishing the Stanford Advanced Melanoma Program—a world-class advanced melanoma center of excellence on the West Coast.
SCI member Marvin Langston, PhD, was recently named a member of the inaugural cohort of Cancer Moonshot Scholars. We spoke with him to learn more about his project that will be funded by the program, his research interests, and what advice he would give students pursuing a career in cancer research.
Since its establishment in 1978, the Stanford Cancer Biology PhD Program has been dedicated to training the next generation of exceptional scientists who will significantly contribute to cancer research.
We spoke to Stanford Cancer Institute member Quynh-Thu Le, MD, about the research she’s most excited about and advice she would give early-career cancer researchers.
The Stanford Cancer Institute Community Advisory Board plays a critical role in ensuring that the SCI meets the needs of our communities by threading our community's diverse perspectives and experiences into the fabric of our initiatives.
The program’s main objective is to provide susceptible communities with the proper melanoma resources and education to catch the disease in its early stages when it is much more treatable.
For those whose thoughts of participating in a cancer clinical trial invoke images of guinea pigs and untested treatments, they may be comforted to learn about the Stanford Cancer Institute’s Scientific Review Committee.
The Stanford Cancer Survivorship Program’s mission is to improve the experience and health outcomes of people living with and beyond cancer by advancing survivorship research and access to clinical services and educating healthcare professionals in the science of survivorship care.
Non-English speaking cancer patients and their families can hit barriers at every turn. Did you know that over 80 different languages are spoken by our patients? Stanford Interpretation and Translation Services assist with both verbal and written translation. Their most requested languages are Spanish, Mandarin, Vietnamese, Cantonese, and Russian. Followed closely by American Sign Language (ASL), Korean, and Farsi. We sat down with interpreter/translator Elena Kozak, PhD, MA, to learn more.
We are so excited to have Steven Corsello, MD, join Stanford Medicine! During Colorectal Cancer Awareness Month we sat down with Dr. Corsello to learn about his brand new lab, emerging GI therapies, and so much more.
A big welcome to Division of Blood & Marrow Transplantation and Cellular Therapy's new faculty member Melody Smith, MD, MS. During Black History and Cancer Prevention Month, we sat down with Dr. Smith to learn more.
Congratulations to Andrea Chaikovsky, who recently successfully defended her PhD! We caught up with the newly minted Dr. Chaikovsky to learn more.
The Investigational Drug Service (IDS) is a licensed pharmacy that provides support and guidance for the safe and efficient conduct of clinical drug trials. We met with these stellar research pharmacists and technicians working behind the scenes to bring novel treatments to our cancer patients to learn more.
During Breast Cancer Awareness Month we spoke to Stanford neurosurgery instructor Maxine Umeh Garcia, PhD, about her exciting breast cancer research, cancer disparities, community engagement, and the importance of mentorship.
October is Breast Cancer Awareness Month. We spoke with SCI leader and breast oncologist Allison Kurian, MD, MSc, about the latest advances in breast cancer screening, and her efforts to identify cancer prevention and treatment strategies that are personalized to a patient’s individual risk level.
Women represent only ~6% of board-certified neurosurgeons in the U.S. Moreover, only a handful of female neurosurgeons hold positions of national leadership. During Women in Medicine Month, we spoke with board-certified neurosurgeon and SCI member Melanie Hayden Gephart, MD.
We spoke with hematologist Gabriel Mannis, MD, assistant professor of medicine, who is leading clinical trial efforts at Stanford to find better ways to treat patients with acute myeloid leukemia (AML), and ultimately provide them with lasting remission.
Congratulations to our Cancer Biology trainees who received the National Science Foundation’s 2021 Graduate Research Fellowship Program (GRFP) award! We spoke with Jeremy D’Silva, Hudson Tyler Horn, and Catherine Zhang to learn more.
Congratulations to Stanford Cancer Biology trainee Emily Ashkin for being named a 2021 Howard Hughes Medical Institute Gilliam Fellow! We recently spoke to Emily to learn more.
Kamir Hiam-Galvez is a postdoctoral fellow working in SCI member Ansuman Satpathy's lab. An immunologist by training, Kamir shared with us about how his journey in cancer research began, and what he's focusing on now in the lab.
In the Spotlight
We are proud to feature the voices of cancer research at Stanford, from the bench to the clinic. The SCI Spotlight connects with Stanford cancer researchers and trainees to provide insight into the work we are doing to diagnose, treat, and prevent cancer.
We are always looking for ways to highlight the accomplishments of our faculty, trainees, and staff. Please contact us if you have any awards or publications you would like us to amplify.